Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew M Heeney

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
American Journal of Hematology|March 24, 2017
Neonatal anemia: Revisiting the enigmatic pyknocyteMichele L Nassin, Jo-Anne Vergilio, Matthew M Heeney, et al.
Pediatric Hematology and Oncology|July 27, 2019
Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosisSerena I Tripodi, Robert C Shamberger, Matthew M Heeney, et al.
Pediatrics|May 15, 2013
Bacteremia risk and outpatient management of febrile patients with sickle cell diseaseMarc N Baskin, Xin Lyn Goh, Matthew M Heeney, et al.
The Journal of Laboratory and Clinical Medicine|April 5, 2003
UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemiaMatthew M Heeney, Thad A Howard, Sherri A Zimmerman, et al.
American Journal of Hematology|April 11, 2018
The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic reviewSamir K Ballas, Amer M Zeidan, Vu H Duong, et al.
Analytical Chemistry|January 28, 2010
High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urineDamon S Anderson, Matthew M Heeney, Udo Roth, et al.
Journal of Pediatric Hematology/Oncology|May 6, 2004
Chemical and functional analysis of hydroxyurea oral solutionsMatthew M Heeney, Matthew R Whorton, Thad A Howard, et al.
Pediatric Blood & Cancer|March 31, 2021
A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell diseaseEmily M Harris, Emily Vilk, Matthew M Heeney, et al.
American Journal of Hematology|January 7, 2010
Resolution of cerebral artery stenosis in a child with sickle cell anemia treated with hydroxyureaRachael F Grace, Henry Su, Laureen Sena, et al.
Pediatric Blood & Cancer|June 7, 2007
Sickle cell disease caused by Hb S/Québec-CHORI: treatment with hydroxyurea and responseVenée N Tubman, Carolyn M Bennett, Hong-yuan Luo, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
American Journal of Hematology|March 24, 2017
Neonatal anemia: Revisiting the enigmatic pyknocyteMichele L Nassin, Jo-Anne Vergilio, Matthew M Heeney, et al.
Pediatric Hematology and Oncology|July 27, 2019
Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosisSerena I Tripodi, Robert C Shamberger, Matthew M Heeney, et al.
Pediatrics|May 15, 2013
Bacteremia risk and outpatient management of febrile patients with sickle cell diseaseMarc N Baskin, Xin Lyn Goh, Matthew M Heeney, et al.
The Journal of Laboratory and Clinical Medicine|April 5, 2003
UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemiaMatthew M Heeney, Thad A Howard, Sherri A Zimmerman, et al.
American Journal of Hematology|April 11, 2018
The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic reviewSamir K Ballas, Amer M Zeidan, Vu H Duong, et al.
Analytical Chemistry|January 28, 2010
High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urineDamon S Anderson, Matthew M Heeney, Udo Roth, et al.
Journal of Pediatric Hematology/Oncology|May 6, 2004
Chemical and functional analysis of hydroxyurea oral solutionsMatthew M Heeney, Matthew R Whorton, Thad A Howard, et al.
Pediatric Blood & Cancer|March 31, 2021
A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell diseaseEmily M Harris, Emily Vilk, Matthew M Heeney, et al.
American Journal of Hematology|January 7, 2010
Resolution of cerebral artery stenosis in a child with sickle cell anemia treated with hydroxyureaRachael F Grace, Henry Su, Laureen Sena, et al.
Pediatric Blood & Cancer|June 7, 2007
Sickle cell disease caused by Hb S/Québec-CHORI: treatment with hydroxyurea and responseVenée N Tubman, Carolyn M Bennett, Hong-yuan Luo, et al.
Pageof 10